India’s obesity crisis is colliding with a transformative moment in treatment, as GLP-1 therapies and a key court ruling on ...

Speakers at the Institute for Value-Based Medicine event held September 18, 2025, in Nyack, New York, spoke about methods of managing cardio-renal-metabolic disease.

In Naples, on Wednesday, December 3rd, the IRCCS Fondazione Pascale hosted the congress 'Cancer and Obesity: A Strong Often ...

HealthDay News — Long-term glucagon-like peptide-1 (GLP-1) therapies combined with intensive behavioral therapy are recommended for adults with obesity, according to a special communication from the ...

WHO outlines first-ever global recommendations for GLP-1 medicines in obesity care, stressing long-term use and behavioural support ...

The World Health Organization has released its first global guideline on the use of Glucagon-Like Peptide-1 (GLP-1) therapies ...

A growing trend of using human weight-loss drugs like Ozempic for pets, dubbed 'Ozempets' and 'Ozempups,' is emerging due to ...

The first of its kind medical trial will see cats take a specially-designed weight loss drug designed to help them lose ...

Recent estimates suggest that about 60% of the nation’s cats and dogs have obesity; hundreds of thousands of cats and dogs have diabetes. Better treatments are desperately needed, experts said.

Berberine, a natural compound from plants like Berberis, is gaining attention for its metabolic benefits. It helps manage ...

Whether it happened among distant stars, in Earth’s ancient past, or just recently, Slovak scientists continue to explore new questions about the world and our place in it. This overview brings ...

Researchers have conducted the first study evaluating the impact of obesity on Alzheimer’s disease blood biomarkers (BBMs).